The role of SPET and PET in monitoring tumour response to therapy.
about
Use of (18)F-FDG PET to predict tumor progression and survival in patients with intermediate hepatocellular carcinoma treated by transarterial chemoembolization.Radiofrequency ablation of lung tumors: imaging features of the postablation zoneCharacteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules.Evaluation of treatment response for breast cancer: are we entering the era of "biological complete remission"?Positioning of 18F-fluorodeoxyglucose-positron emission tomography imaging in the management algorithm of hepatocellular carcinoma.
P2860
The role of SPET and PET in monitoring tumour response to therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The role of SPET and PET in monitoring tumour response to therapy.
@ast
The role of SPET and PET in monitoring tumour response to therapy.
@en
type
label
The role of SPET and PET in monitoring tumour response to therapy.
@ast
The role of SPET and PET in monitoring tumour response to therapy.
@en
prefLabel
The role of SPET and PET in monitoring tumour response to therapy.
@ast
The role of SPET and PET in monitoring tumour response to therapy.
@en
P1476
The role of SPET and PET in monitoring tumour response to therapy.
@en
P2093
Chariklia Giannopoulou
P2888
P304
P356
10.1007/S00259-003-1208-Z
P577
2003-06-14T00:00:00Z